ECSP077208A - POTASSIUM CHANNEL INHIBITORS - Google Patents

POTASSIUM CHANNEL INHIBITORS

Info

Publication number
ECSP077208A
ECSP077208A EC2007007208A ECSP077208A ECSP077208A EC SP077208 A ECSP077208 A EC SP077208A EC 2007007208 A EC2007007208 A EC 2007007208A EC SP077208 A ECSP077208 A EC SP077208A EC SP077208 A ECSP077208 A EC SP077208A
Authority
EC
Ecuador
Prior art keywords
potassium channel
channel inhibitors
inhibitors
compounds
relates
Prior art date
Application number
EC2007007208A
Other languages
Spanish (es)
Inventor
Mark T Bilodeau
Zhicai Wu
John Hartnett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ECSP077208A publication Critical patent/ECSP077208A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a compuestos que tienen la estructura útiles como inhibidores del canal de potasio para tratar arritmias cardíacas y afecciones similares.The present invention relates to compounds that have the structure useful as potassium channel inhibitors for treating cardiac arrhythmias and similar conditions.

EC2007007208A 2004-07-29 2007-01-26 POTASSIUM CHANNEL INHIBITORS ECSP077208A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
ECSP077208A true ECSP077208A (en) 2007-02-28

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007208A ECSP077208A (en) 2004-07-29 2007-01-26 POTASSIUM CHANNEL INHIBITORS

Country Status (15)

Country Link
KR (1) KR20070043985A (en)
AR (1) AR049847A1 (en)
BR (1) BRPI0513793A (en)
CR (1) CR8876A (en)
EC (1) ECSP077208A (en)
IL (1) IL180846A0 (en)
MA (1) MA28980B1 (en)
MX (1) MX2007001188A (en)
NO (1) NO20071107L (en)
PE (1) PE20060382A1 (en)
RU (1) RU2344134C2 (en)
TW (1) TW200607493A (en)
UA (1) UA88018C2 (en)
WO (1) WO2006028590A1 (en)
ZA (1) ZA200700477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2755569A1 (en) * 2009-03-18 2010-09-23 Medicure International Inc. Transdermal pharmaceutical preparation and administration of tirofiban
PT2858987T (en) 2012-06-11 2018-07-04 Bristol Myers Squibb Co Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2140865B2 (en) * 1971-08-14 1979-10-11 Bayer Ag, 5090 Leverkusen 1-imidazolyl-methanephosphonic acid ester, process for their preparation and medicaments containing them
DE19951701A1 (en) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Use of 2-imidazolyl-substituted carbinols for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions
WO2003059873A1 (en) * 2002-01-04 2003-07-24 Poseidon Pharmaceuticals A/S Potassium channel modulators

Also Published As

Publication number Publication date
IL180846A0 (en) 2007-06-03
UA88018C2 (en) 2009-09-10
MX2007001188A (en) 2007-03-21
NO20071107L (en) 2007-04-19
RU2344134C2 (en) 2009-01-20
BRPI0513793A (en) 2008-05-13
WO2006028590A1 (en) 2006-03-16
TW200607493A (en) 2006-03-01
KR20070043985A (en) 2007-04-26
AR049847A1 (en) 2006-09-06
PE20060382A1 (en) 2006-05-15
CR8876A (en) 2007-08-28
RU2007107408A (en) 2008-09-10
ZA200700477B (en) 2009-08-26
MA28980B1 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
ECSP088676A (en) PIRAZOLQUINOLONAS AS POWERFUL PARP INHIBITORS
UY32730A (en) CYP17 INHIBITORS
DOP2010000225A (en) INSECTICIDED ARILPIRROLINAS
CO6511220A2 (en) QUINAZOLINAS AS INHIBITORS OF THE IONIC CHANNELS OF POTASIO
ECSP10010344A (en) AZOLILMETILOXIRANOS, ITS USE AND AGENTS THAT CONTAIN THEM
NO20082298L (en) Potassium channel inhibitors
ECSP088221A (en) ALFA2C ADRENORECEPTORS AGONISTS
EA200970737A1 (en) OXABICYCLOPTANES AND OXABICYCLOPTENS
SV2009003392A (en) ARIL PIRROLIDINS INSECTICIDES
DOP2011000134A (en) WE REACT AS BETA SECRETASA INHIBITORS
UY31560A1 (en) AZOLILMETILOXIRANOS, ITS USE AND AGENTS THAT CONTAIN THEM
UY31688A1 (en) PESTICIDES
CL2008000202A1 (en) Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain.
CO6361894A2 (en) CLEARING COMPOSITIONS OF THE SKIN WITH ACETILCOLINESTERASE INHIBITORS
UA106889C2 (en) N1-ACYL-5-FLORPYRIMIDINONE DERIVATIVES
CR20120117A (en) METHODS FOR THE VEGETATIVE PROPAGATION OF GRAMÍNEAS
PA8667201A1 (en) NEW PHARMACEUTICAL COMPOUNDS
EA201170201A1 (en) PREVENTION AND TREATMENT OF RADIATION DAMAGE
ECSP099738A (en) PIRAZOLONA DERIVATIVES AS PDE4 INHIBITORS
UY29668A1 (en) NEW DERIVATIVES OF HEPTAAZAFENALENO, PROCEDURES FOR ITS OBTAINING, ASE HOW TO USE THESE AS PROTECTIVE AGENTS AGAINST UV RADICACINN.-
BRPI0820698A2 (en) 4-imidazolidinones as kv1.5 potassium channel inhibitors
ECSP077208A (en) POTASSIUM CHANNEL INHIBITORS
CO7170170A2 (en) 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of calcium activated potassium channel
ECSP088994A (en) POTASSIUM CHANNEL INHIBITORS Kv1.5
DOP2005000144A (en) POTASSIUM CHANNEL INHIBITORS